TABLE 1.
Clinical data for patients with leukemia
| Patient no. | Sex | Diagnosis | Amount (%) of surface antigen in samples used for immunophenotypinga
|
||
|---|---|---|---|---|---|
| CD19 | CD7 | CD13 | |||
| 1 | F | ALL, precursor B-cell type | 88 | 10 | |
| 2 | F | ALL, precursor B-cell type | 99.6 | 0.4 | 0.5 |
| 3 | F | ALL, T-cell type | 10 | 93 | 23 |
| 4 | M | ALL, T-cell type | 2 | 98 | 1.4 |
| 5 | F | AML | 0.6 | 2 | 91 |
| 6 | F | ALL, T-cell type | 12 | 85 | 3.5 |
| 7 | F | AML, M2 type | 0.2 | 93 | 24.5 |
| 8 | F | ALL, precursor B-cell type; TEL-AML(+) | 92 | 3 | 1.4 |
a
CD19 is a general B-lineage surface antigen; CD7 is found on T-lineage and ALL, precursor T-cell type, cells; CD13 is found on myeloid lineage cells.